FDA Inspection 1160555 — Vitalant
The FDA completed an inspection of Vitalant on December 16, 2021 in Midland, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 16, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Midland, TX (United States)